Levicent 500mg Tablet contains Levetiracetam, an antiepileptic agent indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby stabilizing neuronal activity and reducing seizure frequency. Levicent is typically prescribed as adjunctive therapy but may also be used as monotherapy depending on clinical assessment. The recommended dosage varies based on patient age, renal function, and seizure type, with adjustments made to optimize therapeutic outcomes while minimizing adverse effects. Common side effects include somnolence, dizziness, headache, and fatigue, though serious adverse reactions are rare. Caution is advised in patients with renal impairment, and dose modification may be necessary. Levicent does not typically induce significant drug interactions but should be used under medical supervision, particularly when combined with other antiepileptic drugs. Regular monitoring of clinical response and tolerability is essential to ensure effective seizure control. This medication should be stored in a cool, dry place, away from direct sunlight and out of reach of children. Patients are advised to adhere strictly to prescribed dosing schedules and consult their healthcare provider before making any changes.